Schizophrenia and addiction are closely linked, and the best-supported way to treat them is at the same time, by one coordinated team, rather than one after the other. Nearly half of people with schizophrenia have a lifetime history of a substance use disorder, and untreated substance use makes psychosis harder to manage. At Connected Recovery in Van Nuys, Los Angeles, our dual diagnosis program treats substance use and co-occurring mental health disorders together, in a 12-bed setting with 24/7 medical supervision.
This guide is for people living with both conditions and for the families who are worried about them. It explains how common the overlap is, why it happens, how to tell substance-induced psychosis from schizophrenia, what withdrawal involves, and what good treatment looks like.
TL;DR
- Substance use disorders are very common in schizophrenia: a 2009 review reports that nearly half of people with schizophrenia have a lifetime history of one, and rates climb toward 80% when tobacco is counted.
- Substance use can worsen disorganized thinking, and some people stop their psychiatric medication because it interferes with the effect of alcohol or cannabis.
- Some substances cause psychosis that fades with abstinence, but a minority of cases persist and become schizophrenia-spectrum diagnoses, so a careful assessment matters.
- Integrated treatment, where medication, therapy and addiction care are coordinated, is the evidence-based standard.
- Detox for someone with a psychotic illness is best done under round-the-clock medical supervision, followed by a written plan for what comes next.
Table of Contents
- How common is addiction in people with schizophrenia?
- Why the two conditions go together
- Can drugs or alcohol cause schizophrenia?
- Signs the two conditions are happening together
- What detox and withdrawal involve when psychosis is part of the picture
- What effective treatment looks like
- Why a small residential setting helps
- What we do at Connected Recovery
- Our perspective
- Talking with us about admission
- FAQ
- Sources
How common is addiction in people with schizophrenia?
Very common, and far more than in the general population. A 2009 review by Nora Volkow, director of the National Institute on Drug Abuse, states that nearly half of people with schizophrenia have a lifetime history of a substance use disorder. A 2016 review by Manseau and Bogenschutz puts lifetime rates close to 80% when tobacco use is included.
The substances most often involved are tobacco, alcohol, cannabis and cocaine. Volkow's review, drawing on national survey data, lists ranges that are wide because studies differ: nicotine use among people with schizophrenia at 60% to 90%, cannabis at 17% to 80%, alcohol problems at 21% to 86%, and cocaine dependence at 23%.

Alcohol deserves its own mention. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) reports that people with schizophrenia and related psychotic disorders have three times the general population's risk of heavy alcohol use. One meta-analysis it cites found a lifetime prevalence of alcohol use disorder of 24.3% in schizophrenia. In one American study of 404 people, 36.4% had developed alcohol use disorder before their first episode of psychosis.
The takeaway for families: if your relative has schizophrenia and is drinking or using drugs, that is not unusual and it is not a character flaw. It is one of the best-documented patterns in psychiatry, and it has a recognized treatment path.
Why the two conditions go together
There is no single reason, and the research points to several that overlap.
Shared biology. The NIAAA attributes the high co-occurrence in part to shared neurobiological mechanisms, including dysfunction in the brain's reward circuitry. The brain systems involved in motivation and pleasure are the same ones that substances act on.
More risk factors, more complexity. Volkow argues that the risk factors for addiction in schizophrenia are more numerous and complex than in the general population. That is one reason the pairing is linked to poorer outcomes, higher illness burden and higher mortality.
Symptom relief that backfires. Many people use alcohol, cannabis or other substances to quiet anxiety, sleeplessness, isolation or distressing symptoms. In the short term it can feel like it works. Over time the substance usually deepens the problem. The American Psychiatric Association notes that substance use can worsen disorganized thinking and behavior in schizophrenia, and that some patients stop taking their medications when they feel the medication interferes with the effect of cannabis or alcohol.
That last point is the one families see most clearly: a missed dose is often the first step in a relapse of psychosis.
Can drugs or alcohol cause schizophrenia?
Not in the way the phrase "drug-induced schizophrenia" suggests, but substances can cause psychosis, and in some people they can unmask or contribute to a lasting illness. Getting this distinction right shapes treatment.
Substance-induced psychosis
The VA/DoD clinical practice guideline for first-episode psychosis and schizophrenia (September 2023) lists substances that can cause or unmask psychosis, including alcohol, cannabis, hallucinogens such as phencyclidine (PCP), anxiolytics and stimulants such as cocaine. It also says that withdrawal from alcohol or sedatives must be considered when clinicians work out what is causing someone's symptoms.
Psychosis caused by a substance usually resolves after abstinence and withdrawal. The NIAAA notes, however, that about 25% of cases may persist and result in schizophrenia-spectrum diagnoses.
Cannabis and vulnerability
The APA says cannabis increases the risk of schizophrenia in vulnerable young people and may complicate the course of the illness. The Canadian schizophrenia guidelines add that cannabis appears to be an independent risk factor for persistent psychotic disorders, particularly in people at genetic risk, and that a meta-analysis found cannabis users develop psychosis about 2.7 years earlier than non-users.
Clues that point to an underlying illness
The same Canadian guidelines list signs that psychosis is more than a substance effect:
- Symptoms persist after the person stops using.
- Symptoms are out of proportion to the substance or amount used.
- There is a family history of schizophrenia.
- There are typical positive symptoms, such as hearing voices that comment on what the person is doing.
- There are negative or cognitive symptoms, such as withdrawal, flat emotion or trouble concentrating.
A 2026 clinical adviser document on opioid use disorder makes a similar point: psychiatric symptoms that predate sustained opioid use or persist after weeks to months of abstinence are more likely to be an independent disorder, while new psychosis during active use should be reassessed once intoxication or withdrawal has cleared.
In practice, this means the diagnosis often cannot be settled on day one. It needs a stable, substance-free period and observation by clinicians, which is one of the strongest arguments for a supervised residential setting.
Signs the two conditions are happening together
Families often notice a pattern before any label is applied:
- Hallucinations, paranoia or confused speech that get worse after drinking or using, or that do not go away between episodes.
- Stopping medication, skipping appointments or saying the medication "gets in the way."
- Withdrawing from friends and family, with a sharp drop in self-care or daily functioning.
- Repeated emergency room visits, hospital stays or run-ins with the law. A 2021 study of outpatients with schizophrenia linked substance use to higher rates of hospitalization, incarceration and emergency service use.
- Cravings or withdrawal symptoms, such as shaking, sweating or agitation, when substance use stops.
When it is an emergency
The SMICA clinical document says initial triage should assess for suicidality, homicidality, acute psychosis and severe withdrawal. If someone is talking about harming themselves or others, is acutely confused or seeing things that are not there and is in danger, or is having severe withdrawal such as seizures, call 911. For thoughts of suicide, call or text 988, the Suicide and Crisis Lifeline. Once the immediate danger has passed, the next step is a medical assessment and a planned admission.
What detox and withdrawal involve when psychosis is part of the picture
Withdrawal is where the two conditions can collide. Alcohol and sedative withdrawal can itself cause confusion and hallucinations, which can look like a flare of schizophrenia. This is why the VA/DoD guideline tells clinicians to consider withdrawal in the differential diagnosis.
A few facts families should know, from a 2021 review of medications for alcohol use disorder:
- Acute alcohol withdrawal can involve autonomic hyperactivity (racing heart, sweating, tremor) for up to five days. Most cases, about 85%, do not need medication, but the minority that do can become dangerous quickly, and it is hard to predict who they are.
- The FDA-approved medications for alcohol use disorder (disulfiram, naltrexone and acamprosate) are not treatments for withdrawal. They should be started only after detoxification or established abstinence.
- The American Psychiatric Association's practice guideline suggests acamprosate or naltrexone for moderate-to-severe alcohol use disorder in people who want to cut down or quit, and recommends against choosing disulfiram as initial treatment.
For opioids, the 2026 SMICA document says medications for opioid use disorder (buprenorphine, methadone or naltrexone) should be offered on day one and continued even while psychiatric diagnoses are still being clarified. It also notes that co-occurring psychiatric conditions are associated with higher overdose risk, poorer treatment retention, and higher hospitalization and suicide risk. That is a reason to start treatment in a medically supervised setting rather than waiting for the ideal moment.
Our medical detox is medically supervised around the clock, and our medication-assisted treatment is part of the same program, so withdrawal and the first steps of recovery are handled in one place.
What effective treatment looks like
The research on treatment is consistent across two decades: do it together, and do it in a coordinated way.
Integrated care is the standard
A consensus panel of experts described integrated treatment as the evidence-based standard of care. It includes baseline assessment, substance use screening, ongoing monitoring, coordinated care, medication management for psychosis, and psychosocial work such as social skills training, motivational enhancement, psychoeducation and relapse prevention. The same panel notes that the effect of substance use on schizophrenia varies by substance, route, severity and stage of use. A 2026 review points to the New Hampshire Dual Diagnosis Study as evidence that integrated treatment is the most effective option, and Manseau and Bogenschutz conclude that treating both in an integrated way improves functional and clinical outcomes.
Medication that supports both goals
A 2024 expert review in Annals of General Psychiatry reports that partial dopamine agonists (aripiprazole, cariprazine, brexpiprazole) have shown good control of psychotic symptoms and substance use with a favorable safety profile, and that long-acting injectable antipsychotics improve adherence. It also found that among people with opioid dependence, antipsychotic adherence rose by more than 50% in periods that followed methadone adherence. In other words, treating the addiction can make the psychiatric medication work better. The review adds that people on second-generation antipsychotics need close follow-up of cardiometabolic health, and that involving patients in decisions improves satisfaction and adherence.
Medication choices belong to the prescribing physician and the patient. Never stop or change an antipsychotic on your own, and do not start or stop any addiction medication without medical guidance.
Therapy adapted to the illness
The NIAAA notes a role for group therapy using cognitive behavioral therapy, motivational enhancement therapy or contingency management, with CBT modified to account for cognitive, interpersonal and motivational deficits. It also observes that alcohol may worsen the cognitive deficits and reduced executive functioning common in chronic psychotic illness, so sobriety itself supports the thinking skills that therapy relies on.
When residential care fits
The NIAAA says the most widely tested community model for severe mental illness is assertive community treatment, and that residential programs integrating mental health and substance use treatment may be especially indicated for people who are homeless or who have not responded well to other interventions. Many families reach a similar point on their own: outpatient visits are not enough when relapse keeps repeating.
The 2024 review also warns that dual schizophrenia and substance use is underdiagnosed and undertreated because full diagnostic assessments are often not done. A residential stay gives clinicians weeks of observation to do exactly that assessment properly.
Follow-up matters as much as the stay
The 2026 review recommends follow-up care for one to two years, with regular monitoring of symptom recurrence, substance use, medication adherence and daily functioning. Recovery from both conditions is a long process, and the plan for leaving treatment should be written before the person leaves.
Why a small residential setting helps
People with psychosis often struggle in crowded, loud, high-turnover environments. Someone who is sensitive to stimulation, wary of strangers or easily overwhelmed can disengage from treatment long before it has a chance to work. A small program changes that. With 12 beds, our staff know each person, notice small changes in sleep, mood or thinking, and can adjust a plan quickly. The setting is built to feel like a private retreat rather than an institution, which many families say matters when they are asking a loved one to accept help.

Continuity matters too. The 2024 review calls shared electronic health records an essential component of integrated care because they simplify communication between professionals. Our model runs from detox through residential treatment to aftercare, so the people planning discharge are the ones who have been part of the person's care throughout.
What we do at Connected Recovery
We are an accredited, 12-bed boutique facility in Van Nuys, Los Angeles, serving adults. Here is how our programs map to what the evidence describes:
| What the evidence calls for | How we provide it |
|---|---|
| Safe withdrawal and early stabilization | Medical detox with 24/7 medical supervision |
| Treating both conditions together | Dual diagnosis treatment for substance use and co-occurring mental health disorders |
| Medication for addiction | Medication-assisted treatment |
| Structured therapy and time to stabilize | Residential treatment with individual therapy, group therapy and a family program |
| Long-term follow-up | Aftercare planning, case management and discharge planning |
If you want more on how care levels connect, our guide to the continuum of care walks through it, and our dual diagnosis rehab guide explains how to choose a program that treats both conditions. For the therapy side, see DBT for substance use.
Our perspective
We see the same mistake described again and again in the research: treating the addiction first and the mental illness later, or the reverse. Each condition keeps feeding the other, so the plan that works is one team, one plan, both conditions.
That is why we stay small. Twelve beds means the person in the room is not a chart number. It means 24/7 medical supervision is attached to a face we know, and that a change in sleep, mood or thinking is noticed and acted on.
It also means we plan for the day after discharge from the first week. Detox, residential care, medication-assisted treatment, relapse prevention and aftercare belong to one continuous plan. Families should not have to rebuild that plan from scratch at every handoff.
If you are reading this because someone you love is struggling with both, you are not late and you are not alone. Call us and we will talk through the situation with you, confidentially.
Jim
Talking with us about admission
If you are weighing residential care for yourself or a family member, our admissions team can talk through what is happening, what level of care fits and how coverage or private pay works. We do not publish prices, because every admission depends on the person's needs and the plan that pays for it. Conversations are confidential, and we understand that discretion matters.

You can see all of our services on the programs page, or reach us through Connected Recovery to start an admission conversation.
FAQ
Which substance do people with schizophrenia use most?
Tobacco is the most common, followed by alcohol, cannabis and cocaine, according to a 2016 review. Alcohol is the substance most often involved in a clinical addiction diagnosis, and the NIAAA reports a 24.3% lifetime prevalence of alcohol use disorder in schizophrenia. Which substance matters most varies by person and region.
Is schizophrenia treated differently when alcohol is involved?
The underlying approach is the same, but the plan has to cover both. Primary psychotic disorders with alcohol use disorder usually need long-term antipsychotic medication and psychosocial interventions alongside alcohol treatment. Alcohol withdrawal is managed first, and relapse-prevention medications for alcohol start only after detox or established abstinence.
Can someone fully recover from both?
Many people reach lasting stability, but it usually takes ongoing care rather than a single stay. Integrated treatment is associated with better clinical and functional outcomes, and follow-up for one to two years is recommended after substance-induced psychosis. A written aftercare plan, regular monitoring and family involvement all help.
How do I know if it is substance-induced psychosis or schizophrenia?
Only a clinical assessment can tell. Symptoms that continue after weeks to months without substances, a family history of schizophrenia, and typical features such as voices commenting on the person's actions point toward an underlying illness. A supervised, substance-free period gives clinicians the time to observe this safely.
Should I stop my loved one's medication if it seems to make things worse?
No. Stopping antipsychotic medication suddenly can trigger a relapse. Raise any concerns about side effects or interactions with the prescribing physician, who can adjust the plan safely. If there is a crisis, call 911 or 988.
Sources
- NIAAA: Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
- Volkow (2009): Substance Use Disorders in Schizophrenia
- Manseau and Bogenschutz (2016): Substance Use Disorders and Schizophrenia
- American Psychiatric Association: Schizophrenia
- VA/DoD Clinical Practice Guideline: First Episode Psychosis and Schizophrenia (pocket card, 2023)
- Canadian Schizophrenia Guidelines
- SMICA: OUD Treatment and Concerns with Co-Occurring Psychiatric Conditions (2026)
- Consensus recommendations: Improving the Care of Individuals with Schizophrenia and Substance Use Disorder
- Neyra et al. (2024): Management of schizophrenia and comorbid substance use (PMC)
- Neyra et al. (2024): Annals of General Psychiatry
- Paparrigopoulos et al. (2026): Substance Use Disorders and the Psychosis Spectrum
- Mason and Heyser (2021): Alcohol Use Disorder: The Role of Medication in Recovery
- Chang et al. (2021): Problematic Drug Use Among Outpatients With Schizophrenia
